Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CITA Biomedical SEC Filings Now Up-to-Date.


BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Oct. 26, 1999--

CITA CITA Committee for the Implementation of Textile Agreements
CITA Canadian Institute for Theoretical Astrophysics
CITA Center for Information Technology Accommodation (US; now the GSA IT Accommodation Division) 
 Biomedical Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
: DTOXE) announced today that it has completed SEC 10Q filings for both the three-month periods ending March 31, 1999 and June 30, 1999.

According to CITA's president, Joseph Dunn, the Company is now current with all of its SEC filings and in full compliance with NASD NASD

See: National Association of Securities Dealers


NASD

See National Association of Securities Dealers (NASD).
 requirements for continued listing on the OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 Electronic Bulletin Board.

In accordance with NASD compliance policies, the Company's ticker symbol was temporarily changed to DTOXE, and should be returned to the original symbol DTOX, by the end of the week.

Visit CITA's website at http://www.citabio.com and http://www.cita1.com for more information.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 26, 1999
Words:114
Previous Article:ChannelHealth Announces Contracts with Healthcare Organizations for Physician Homebase Service; 7,200 Physicians to Benefit from Incorporating the...
Next Article:Mylan Announces Second Quarter Results.



Related Articles
CITA Biomedical to Bring SEC Filings Up-to-Date.
CITA Biomedical Receives Standard & Poor's Approval For Listing in Its Comprehensive Market Access Program.
EquityAlert.com Announces Investment Opinion, No. 6.
CITA Biomedical Delivers Significant Enhancements to CubeCentral.com.
CITA Biomedical and Aviation Industries Sign Settlement Agreement; Purchases CITA Americas for Common Stock.
A new weapon in the war on drugs: corporation unveils a new treatment for substance abusers. (Newsmakers).
Four assume roles on AASA's governing board. (Executive Committee Newcomers).
Multimodal could work: expert.
Pay-for-performance program focuses on Web-based quality data.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles